Automated methodology for post-approval management of a process control strategy

被引：0
|
作者：
Smith, Phillip [1 ]
Marques, Bruno [1 ]
Wiley, Trevor [1 ]
Goklen, Kent [1 ]
机构：
[1] GlaxoSmithKline, Downstream Proc Dev, Upper Merion, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
731-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Post-approval safety issues not related to level of drug innovation
    Reactions Weekly, 2013, 1474 (1) : 3 - 3
  • [42] Post-approval monitoring enhanced by use of a slate/tablet PC
    Foley, P. L.
    Moody, D. L.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2007, 46 (04): : 113 - 113
  • [43] Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305
    Wu, Zhouyi
    Xu, Gangling
    He, Wu
    Yu, Chuanfei
    Huang, Wanqiu
    Zheng, Shirui
    Kang, Dian
    Xie, Michael H.
    Cao, Xingjun
    Wang, Lan
    Wei, Kaikun
    ANTIBODY THERAPEUTICS, 2023, 6 (03) : 194 - 210
  • [44] Analysis of Typical Problems of Moderate Change in Post-approval Chemical Drugs
    Yuan, Jianlong
    Zhang, Lingna
    Chen, Qingyu
    Huang, Rongzhen
    Chinese Journal of Pharmaceuticals, 2023, 54 (10) : 1517 - 1520
  • [45] Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use
    Maltais, S.
    Ewald, G. A.
    Keebler, M. E.
    Schlendorf, K. H.
    Boyce, S. W.
    Najjar, S. S.
    Pagani, F. D.
    Aaronson, K. D.
    Jeevanandam, V.
    Milano, C. A.
    Rogers, J. G.
    Love, R. B.
    Mahr, C. W.
    Pham, D. T.
    Kiernan, M. S.
    Kormos, R. L.
    Teuteberg, J. J.
    Silvestry, S. C.
    McGee, E. C.
    Gordon, R. A.
    Mallidi, H. R.
    Frazier, O. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S195 - S196
  • [46] Berlin Heart EXCOR and ACTION post-approval surveillance study report
    Zafar, Farhan
    Conway, Jennifer
    Bleiweis, Mark S.
    Al-Aklabi, Mohammed
    Ameduri, Rebecca
    Barnes, Aliessa
    Bearl, David W.
    Buchholz, Holger
    Church, Stephanie
    Do, Nhue L.
    Duffy, Vicky
    Dykes, John C.
    Eghtesady, Pirooz
    Fisher, Lauren
    Friedland-Little, Joshua
    Fuller, Stephanie
    Fynn-Thompson, Francis
    George, Kristen
    Gossett, Jeffrey G.
    Griffiths, Eric R.
    Griselli, Massimo
    Hawkins, Beth
    Honjo, Osami
    Jeewa, Aamir
    Joong, Anna
    Kindel, Steven
    Kouretas, Peter
    Lorts, Angela
    Machado, Desiree
    Maeda, Katsuhide
    Maurich, Andrea
    May, Lindsay J.
    McConnell, Patrick
    Mehegan, Mary
    Monge, Michael
    Morales, David L. S.
    Murray, Jenna
    Niebler, Robert A.
    O'Connor, Matthew
    Peng, David M.
    Phelps, Christina
    Philip, Joseph
    Ploutz, Michelle
    Profsky, Michael
    Reichhold, Allison
    Rosenthal, David N.
    Said, Ahmed S.
    Schumacher, Kurt R.
    Si, Ming-Sing
    Simpson, Kathleen E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : 251 - 259
  • [47] Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients
    Baksh, Sheriza N.
    Gellad, Walid F.
    Alexander, G. Caleb
    DRUG SAFETY, 2016, 39 (05) : 375 - 380
  • [48] FDA's post-approval studies continue to suffer delays and setbacks
    Cassandra Willyard
    Nature Medicine, 2014, 20 : 1224 - 1225
  • [49] Navigating a Device Post-Approval Study During Covid-19
    Nair, Devi
    Garner, John
    Ciuffo, Allen
    MacGregor, John
    Rhodes, Troy
    Shah, Anand
    Hamdan, Firas
    Pickett, Robert
    Ostrom, Matthew
    Hopper, Donald
    Wold, Nicholas
    Kantor, Gena
    Tabereaux, Paul
    CIRCULATION, 2022, 146
  • [50] DESIGN INNOVATION FOR EFFICIENT POST-APPROVAL DRUG UTILIZATION AND EFFECTIVENESS STUDIES
    Saragoussi, D.
    Rouleau, A.
    Capart, P.
    Deveras, C. C.
    Brett, N.
    Ognar, R.
    Gazay, H.
    Payne, K.
    VALUE IN HEALTH, 2020, 23 : S456 - S456
12345